证券代码：301101 证券简称：明月镜片 公告编号：2023-024 明月镜片股份有限公司 关于举办 2022 年度网上业绩说明会的公告 会议召开方式：网络互动方式 二、参加人员 董事长谢公晚先生、董事会秘书兼副总经理曾哲先生、独立董事张银杰女 士、财务总监尉静妮女士。 会议召开地点：价值在线（www.ir-online.cn） 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 5 月 25 日（星期四）15:00-17:00 会议召开时间：2023 年 5 月 25 日（星期四）15:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会 议 问 题 征 集 ： 投 资 者 可 于 2023 年 5 月 25 日 前 访 问 网 址 https://eseb.cn/14JeIetaQyQ 或使用微信扫描下方小程序码进行会前 提问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普 遍关注的问题进行回答。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： 明月镜片股份有限公 ...

明月镜片股份有限公司 2023 年第一季度报告 证券代码：301101 证券简称：明月镜片 公告编号：2023-019 明月镜片股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 171,613,712.00 | 136,199,535.62 | 26.00 | | 归属于上市公司股东的净利润（元） | 35,050,749.84 | 22,113 ...

Financial Performance - The company's operating revenue for 2022 was ¥623,065,041.29, representing an increase of 8.25% compared to ¥575,569,283.16 in 2021[18]. - Net profit attributable to shareholders for 2022 was ¥136,185,210.67, a significant increase of 65.89% from ¥82,094,094.80 in 2021[18]. - The basic earnings per share for 2022 was ¥1.0137, up 24.41% from ¥0.8148 in 2021[18]. - The total assets at the end of 2022 amounted to ¥1,659,522,369.65, reflecting a growth of 4.02% from ¥1,595,387,682.94 at the end of 2021[18]. - The company's total revenue for 2022 was CNY 623.07 million, an increase of 8.25% compared to the previous year[53]. - Revenue from lens business reached CNY 477.80 million, up 5.63% year-on-year, while raw material revenue surged by 44.93% to CNY 89.15 million[55]. - The company's gross profit margin for lens products was 60.04%, reflecting a year-on-year increase of 2.97%[56]. - The company reported a net profit margin of 18% for 2022, reflecting improved operational efficiency and cost management[182]. Dividend and Capital Management - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders based on a total share capital of 134,341,400 shares as of December 31, 2022[4]. - The company will increase its capital reserve by converting 5 shares for every 10 shares held by shareholders[4]. - The company distributed a cash dividend of 5.30 RMB per 10 shares, totaling 71,200,942 RMB (including tax) to shareholders based on a total share capital of 134,341,400 shares[152]. - The company plans to distribute a cash dividend of RMB 3.00 per 10 shares, totaling RMB 40,302,420, which represents 100% of the profit distribution amount[153]. - The total share capital after the capital reserve conversion will increase to 201,512,100 shares, with 67,170,700 shares being converted from capital reserves[153]. Research and Development - The company has a total of 152 patents as of December 31, 2022, including 21 invention patents, 110 utility model patents, and 21 design patents[46]. - The company has invested in brand building, enhancing its market influence through advertising and partnerships with popular media programs[42]. - The company will increase R&D investment and collaborate with renowned universities to enhance its technological capabilities, including establishing research centers with Shanghai University of Technology and Nanjing University of Technology[99]. - Research and development expenses increased by 25.21% to ¥22,369,466.61, reflecting the company's increased investment in R&D[64]. - Investment in R&D has increased by 15%, focusing on innovative technologies to maintain competitive advantage[184]. Market Position and Strategy - The company maintained a market share of 10.7% in the Chinese lens market, ranking first according to Euromonitor data[27]. - The company aims to become the leading brand in the Chinese lens market, withdrawing from price wars and focusing on brand development and channel expansion[34]. - The company plans to enhance the promotion of its "Easy Control" series products and expand its market presence in 2023[96]. - The company aims to increase its operational bases from one to four, expanding into Guangdong, Zhejiang, and Anhui provinces in addition to Jiangsu[97]. - The company is exploring potential mergers and acquisitions to strengthen its competitive position, with a budget of 500 million yuan allocated for this purpose[181]. Governance and Compliance - The board of directors has confirmed the accuracy and completeness of the annual report, ensuring no misleading statements or omissions[4]. - The company maintains complete independence from its controlling shareholders in terms of assets, personnel, finance, and operations[120]. - The company has a transparent and fair performance evaluation and incentive mechanism for senior management[115]. - The company has established specialized committees within the board, including a remuneration and assessment committee[115]. - The company has maintained compliance with relevant laws and regulations, ensuring the protection of shareholders' rights[144]. Environmental Responsibility - The company invested a total of ¥2,783,554.98 in environmental governance and protection during the reporting period[168]. - The company has established a third-party cooperation for the detection of wastewater and air pollutants, ensuring compliance with environmental regulations[168]. - The company adopted energy management practices to reduce carbon emissions, including the use of RO wastewater for cleaning purposes[169]. - The company has committed to a "high efficiency, low energy consumption" green production model to support national carbon reduction goals[169]. - The company has no reported administrative penalties related to environmental issues during the reporting period[170]. Employee Management - The total number of employees at the end of the reporting period was 962, including 863 at the parent company and 99 at major subsidiaries[148]. - The company has implemented a competitive and fair salary system, linking salary packages to business performance and development results[150]. - The company has introduced a diversified incentive mechanism to enhance employee motivation and align efforts with business objectives[150]. - The training program covers all levels and positions, enhancing employee skills through both online and offline training methods[151]. - The company has established lean management projects to improve operational efficiency and employee skills[151]. Future Outlook - The company provided a positive outlook for 2023, projecting a revenue growth of 10% to 12% based on market expansion strategies[181]. - New product launches are expected to contribute an additional 200 million yuan in revenue in 2023, focusing on innovative lens technologies[182]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[181]. - Future guidance includes a target of 1.8 billion CNY in revenue for 2023, with a focus on maintaining a sustainable growth trajectory[185]. - The company aims to reduce operational costs by 10% through efficiency improvements and process optimization[183].

明月镜片股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | |------------------------------|------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

明月镜片股份有限公司 投资者关系活动记录表 编号：2022-003 投资者关系 活动类别 √特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位 中信建投证券、Anatole Investment Management Limited、dawn capital、 Dymon Asia Capital (HK) Limited、HBM Partners Hong Kong Limited、 KHAZANAH NASIONAL BERHAD、Manulife Investment Management (Hong Kong) Limited、开域资本（新加坡）有限公司、Pinpoint Asset Management Limited、Polymer Capital Management (HK) Limited、Ponit72、SCHP Management Limited、Strategic Vision Investment Limited、三井住友 德思资产管理株式会社、Tairen Capital Limited、Wil ...

明月镜片股份有限公司 投资者关系活动记录表 编号：2022-005 | --- | --- | --- | |----------------------------------|--------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

明月镜片股份有限公司 2022 年第三季度报告 证券代码：301101 证券简称：明月镜片 公告编号：2022-051 明月镜片股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 明月镜片股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |------------------------------------------------------|------------------|-------------------------|--------------- ...

明月镜片股份有限公司 2022 年半年度报告全文 1 明月镜片股份有限公司 2022 年半年度报告 2022 年 8 月 明月镜片股份有限公司 2022 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人谢公晚、主管会计工作负责人尉静妮及会计机构负责人(会计 主管人员)尉静妮声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中所涉及的未来计划、发展战略等前瞻性描述不构成本公司对投 资者的承诺，敬请投资者注意投资风险。 公司在本半年度报告"第三节 管理层讨论与分析"之"十 公司面临的 风险和应对措施"中详细列示了公司目前经营过程中面临的风险因素，提请 投资者注意阅读并充分关注投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 明月镜片股份有限公司 2022 年半年度报告全文 目录 | --- | --- | |-------|-------------------------- ...

明月镜片股份有限公司 2022 年第一季度报告 1 证券代码：301101 证券简称：明月镜片 公告编号：2022-018 明月镜片股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证季 度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 （一）主要会计数据和财务指标 | --- | --- | --- | --- | |-----------------------------------------------------|------------------|------------------|--------------------------| | | | | | | □ 是 √ 否 | 本报告期 | 上年同期 | 本报告期比上年 ...